Select another study category: Amyotrophic Lateral Sclerosis AnesthesiologyCancer Control/Symptom PreventionCancer, BladderCancer, BrainCancer, BreastCancer, ColorectalCancer, EsophagealCancer, GeneralCancer, GynecologicCancer, Head and NeckCancer, HIV/AIDS MalignancyCancer, LiverCancer, LungCancer, LymphomaCancer, MelanomaCancer, NeuroendocrineCancer, PancreaticCancer, ProstateCancer, RenalCancer, Solid TumorsCardiologyCrohn's DiseaseDiabetes, Type 1Fatty Liver DiseaseHealthy ControlsHepatitisHepatorenal SyndromeLiver Disease RegistryLupusMultiple SclerosisOtherParkinson's DiseasePrimary Sclerosing CholangitisRadiologyRelapsing PolychondritisRheumatoid ArthritisSclerodermaSphincter of Oddi DysfunctionStrokeUrology

---

Lupus

Researchers at BRI and physicians in the Virginia Mason Section of Rheumatology work closely together to understand the pathogenesis of lupus, and identify novel therapies. We participate in multi-center, often international, studies involving both translational and clinical research.

---

To participate in a BRI clinical trial, please contact the study coordinator listed in each of the study links below, or send an e-mail to the Clinical Research Program. Please click on individual studies for more information.

Studies currently accepting study participants:

• A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults with Systemic Lupus Erythematosus
• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE)

Studies currently not accepting study participants:

• A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus